Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 25;18(5):2278.
doi: 10.3390/ijerph18052278.

Perceived Barriers to COVID-19 Testing

Affiliations

Perceived Barriers to COVID-19 Testing

Pearl A McElfish et al. Int J Environ Res Public Health. .

Abstract

(1) Background: Prior studies have documented that access to testing has not been equitable across all communities in the US, with less testing availability and lower testing rates documented in rural counties and lower income communities. However, there is limited understanding of the perceived barriers to coronavirus disease 2019 (COVID-19) testing. The purpose of this study was to document the perceived barriers to COVID-19 testing. (2) Methods: Arkansas residents were recruited using a volunteer research participant registry. Participants were asked an open-ended question regarding their perceived barriers to testing. A qualitative descriptive analytical approach was used. (3) Results: Overall, 1221 people responded to the open-ended question. The primary barriers to testing described by participants were confusion and uncertainty regarding testing guidelines and where to go for testing, lack of accessible testing locations, perceptions that the nasal swab method was too painful, and long wait times for testing results. (4) Conclusions: This study documents participant reported barriers to COVID-19 testing. Through the use of a qualitative descriptive method, participants were able to discuss their concerns in their own words. This work provides important insights that can help public health leaders and healthcare providers with understanding and mitigating barriers to COVID-19 testing.

Keywords: COVID-19 testing; barriers to testing; qualitative; research registry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Stokes E.K., Zambrano L.D., Anderson K.N., Marder E.P., Raz K.M., El Burai Feli S., Tie Y., Fullerton K.E. Coronavirus Disease 2019 Case Surveillance—United States, January 22–May 30 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:759–765. doi: 10.15585/mmwr.mm6924e2. - DOI - PMC - PubMed
    1. Chana J.F.-W., Yip C., To K. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific 2 COVID-19-RdRp/Hel realtime reverse transcription-polymerase chain reaction assay validated 3 in vitro and with clinical specimens. J. Clin. Microbiol. 2020;58:00310–00320. - PMC - PubMed
    1. Carter L.J., Garner L.V., Smoot J.W., Li Y., Zhou Q., Saveson C.J., Sasso J.M., Gregg A.C., Soares D.J., Beskid T.R., et al. Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent. Sci. 2020;6:591–605. doi: 10.1021/acscentsci.0c00501. - DOI - PMC - PubMed
    1. Hadaya J., Schumm M., Livingston E.H. Testing Individuals for Coronavirus Disease 2019 (COVID-19) JAMA. 2020;323:1981. doi: 10.1001/jama.2020.5388. - DOI - PubMed
    1. Tromberg B.J., Schwetz T.A., Perez-Stable E.J., Hodes R.J., Woychik R.P., Bright R.A., Fleurence R.L., Collins F.S. Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States—The NIH RADx Initiative. N. Engl. J. Med. 2020;383:1071–1077. doi: 10.1056/NEJMsr2022263. - DOI - PMC - PubMed